|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/53 | |
| A61K 39/395 |
| (11) | Patento numeris | 2773957 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12846452.6 |
| Europos patento paraiškos padavimo data | 2012-10-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-09-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-11-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/062430 |
| Data | 2012-10-29 |
| (87) | Numeris | WO 2013/066818 |
| Data | 2013-05-10 |
| (30) | Numeris | Data | Šalis |
| 201161554924 P | 2011-11-02 | US |
| (72) |
WEIHOFEN, Andreas, CH
ENGBER, Thomas, US
GRIMM, Jan, CH
|
| (73) |
Biogen International Neuroscience GmbH,
Landis & Gyr Strasse 3, 6300 Zug,
CH
|
| (54) | USE OF AN ANTI-ALPHA-SYNUCLEIN ANTIBODY TO DIAGNOSE AN ELEVATED LEVEL OF ALPHA-SYNUCLEIN IN THE BRAIN |
| USE OF AN ANTI-ALPHA-SYNUCLEIN ANTIBODY TO DIAGNOSE AN ELEVATED LEVEL OF ALPHA-SYNUCLEIN IN THE BRAIN |